Biodesix
|
Year Established:
2005 |
|
|
Website:
biodesix.com/biopharma-solutions/partnering |
|
|
Headquarters:
Boulder, CO, US |
|
|
Company Type:
Mid-Sized Business (10-100M TTM Revenue) |
|
|
Professional Associates:
Colorado BioScience Association |
Biodesix excels as a versatile business partner to pharma companies, offering cutting-edge multi-omic technologies for biomarker discovery, assay development, clinical sample testing and commercialization of diagnostic tests. We provide comprehensive end-to-end diagnostic services, serving industry giants, smaller businesses, and independent labs. With a proven track record of collaboration with over 60 companies and academic medical institutions, Biodesix’s adaptability and commitment to innovation make us an invaluable ally in advancing research and development of therapeutics for cancer and other diseases.
Click here for a list of our publications
Our technology platforms currently include:- Droplet Digital™ PCR (ddPCR)
- Next Generation Sequencing (NGS)
- MALDI-ToF Mass Spectrometry
- Liquid Chromatography Mass Spectrometry (LC-MS)
- ELISA
Biomarker Assay Validation Capabilities:
- Research Use Only (RUO)
- Clinical Trial (CTA) or Investigational Use Only (IUO) Assays
- Companion Diagnostics (CDx)
| Site | Badges | |
|---|---|---|
| Biodesix 2970 Wilderness Place Boulder, CO, 80301 United States | ||
| Biodesix - De Soto 8960 Commerce Dr #6 De Soto,, KS , 66018 United States | ||
Get started
To request access, simply fill out the form below and we will contact you.